Ability of the VITEK 2 Advanced Expert System To Identify β-Lactam Phenotypes in Isolates of Enterobacteriaceae andPseudomonas aeruginosa

ABSTRACT The Advanced Expert System (AES) was used in conjunction with the VITEK 2 automated antimicrobial susceptibility test system to ascertain the β-lactam phenotypes of 196 isolates of the familyEnterobacteriaceae and the species Pseudomonas aeruginosa. These isolates represented a panel of strains that had been collected from laboratories worldwide and whose β-lactam phenotypes had been characterized by biochemical and molecular techniques. The antimicrobial susceptibility of each isolate was determined with the VITEK 2 instrument, and the results were analyzed with the AES to ascertain the β-lactam phenotype. The results were then compared to the β-lactam resistance mechanism determined by biochemical and molecular techniques. Overall, the AES was able to ascertain a β-lactam phenotype for 183 of the 196 (93.4%) isolates tested. For 111 of these 183 (60.7%) isolates, the correct β-lactam phenotype was identified definitively in a single choice by the AES, while for an additional 46 isolates (25.1%), the AES identified the correct β-lactam phenotype provisionally within two or more choices. For the remaining 26 isolates (14.2%), the β-lactam phenotype identified by the AES was incorrect. However, for a number of these isolates, the error was due to remediable problems. These results suggest that the AES is capable of accurate identification of the β-lactam phenotypes of gram-negative isolates and that certain modifications can improve its performance even further.

[1]  Christine C. Sanders,et al.  β-Lactam Resistance in Gram-Negative Bacteria: Global Trends and Clinical Impact , 1992 .

[2]  G. Jacoby,et al.  A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.

[3]  C. Sanders,et al.  Heterogeneity of class I beta-lactamase expression in clinical isolates of Pseudomonas aeruginosa , 1988, Antimicrobial Agents and Chemotherapy.

[4]  Kenneth S. Thomson,et al.  Can Results Obtained with Commercially Available MicroScan Microdilution Panels Serve as an Indicator of β-Lactamase Production among Escherichia coli andKlebsiella Isolates with Hidden Resistance to ExpandedSpectrum Cephalosporins and Aztreonam? , 1998, Journal of Clinical Microbiology.

[5]  A. Medeiros,et al.  Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics , 1997 .

[6]  C. O'callaghan,et al.  Effects of beta-lactamase from gram-negative organisms on cephalosporins and penicillins. , 1968, Antimicrobial agents and chemotherapy.

[7]  A. Harris,et al.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases. , 1975, Journal of general microbiology.

[8]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[9]  E. S. Moland,et al.  Characterization of beta-lactamases in situ on polyacrylamide gels , 1986, Antimicrobial Agents and Chemotherapy.

[10]  H. Goossens,et al.  Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital , 1997, Journal of clinical microbiology.

[11]  E. S. Moland,et al.  Use of Microdilution Panels with and without β-Lactamase Inhibitors as a Phenotypic Test for β-Lactamase Production among Escherichia coli, Klebsiella spp.,Enterobacter spp., Citrobacter freundii, andSerratia marcescens , 1999, Antimicrobial Agents and Chemotherapy.

[12]  J. Waitz Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[13]  C. Sanders beta-Lactamases of gram-negative bacteria: new challenges for new drugs. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[15]  D. Livermore beta-Lactamases in laboratory and clinical resistance , 1995, Clinical microbiology reviews.

[16]  A L Barry,et al.  Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test , 1996, Journal of clinical microbiology.

[17]  P. Bradford,et al.  Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibiotics , 1995, Antimicrobial agents and chemotherapy.

[18]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.